Want to know what's coming next? www.adaptyvbio.com/blog/launch/

But the real metric that matters to us is this: Every week, people are uploading new protein designs to our platform. New companies get started and test their proteins with us. People who wouldn't have been able to test proteins can now do it thanks to our platform. That's what we're building for.

This is also the right time to announce that we raised an $8M seed round led by Ace Ventures earlier this year, with previous investors ByFounders and Founderful doubling down and LongGame and many great angels joining new.

Overall, this year, over 30 companies started using Adaptyv to validate their protein designs - from some of the biggest pharmas to frontier AI labs to many, many techbio startups. We've run hundreds of experiments, tested well over 10,000 proteins this year and are benchmarking the best AI models.

Now, after a year of working with many great partners, we’ve scaled our infrastructure to the point that we're now open to anyone who wants to use our platform!

Today we're dropping the "beta" tag from Adaptyv, launching our new website and announcing our $8M seed round.

When we started Adaptyv a few years ago, our core belief was: AI models for biology are only as good as the lab data they're trained on and the hypotheses they can test in the real world.